Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB for Nephroblastoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for Nephroblastoma.

Most Reported Side Effects for BEVACIZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 12,094 15.5% 3,560 1,814
Death 8,493 10.9% 8,485 726
Diarrhoea 4,911 6.3% 1,110 1,932
Disease progression 4,653 6.0% 1,838 749
Fatigue 4,572 5.9% 1,358 1,294
Nausea 4,357 5.6% 1,050 1,459
Hypertension 4,309 5.5% 534 1,181
Anaemia 3,221 4.1% 587 1,289
Vomiting 3,193 4.1% 794 1,404
Neutropenia 2,875 3.7% 449 720
Pyrexia 2,602 3.3% 512 1,618
Decreased appetite 2,559 3.3% 682 944
Asthenia 2,489 3.2% 790 924
Drug ineffective 2,488 3.2% 493 369
Proteinuria 2,384 3.1% 325 459

Other Indications for BEVACIZUMAB

Product used for unknown indication (9,041) Hepatocellular carcinoma (7,773) Colorectal cancer metastatic (5,474) Ovarian cancer (5,283) Non-small cell lung cancer (4,136) Colon cancer (4,015) Colorectal cancer (2,788) Breast cancer (2,130) Lung neoplasm malignant (1,810) Glioblastoma (1,610)

Other Drugs Used for Nephroblastoma

VINCRISTINE (375) DOXORUBICIN (345) ETOPOSIDE (286) DACTINOMYCIN (278) CARBOPLATIN (228) CYCLOPHOSPHAMIDE (217) IRINOTECAN (104) IFOSFAMIDE (100) MELPHALAN (36) TOPOTECAN\TOPOTECAN (28)

Related Pages

BEVACIZUMAB Full Profile All Nephroblastoma Drugs BEVACIZUMAB Demographics BEVACIZUMAB Timeline